Allogeneic Off-the-Shelf CAR T-Cell Therapy for Relapsed or Refractory B-Cell Malignancies.
Shahid S, Prockop SE, Flynn GC, Mauguen A, White C, Bieler J, McAvoy D, Hosszu K, Cancio MI, Jakubowski AA, Scaradavou A, Boelens JJ, Sauter CS, Perales MA, Giralt SA, Taylor C, Chaudhari J, Wang X, Rivière I, Sadelain M, Brentjens RJ, Kernan NA, O'Reilly RJ, Curran KJ.
Shahid S, et al. Among authors: wang x.
Blood Adv. 2025 Feb 5:bloodadvances.2024015157. doi: 10.1182/bloodadvances.2024015157. Online ahead of print.
Blood Adv. 2025.
PMID: 39908482